Commonwealth Equity Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.97M | Sell |
111,964
-7,119
| -6% | -$587K | 0.01% | 943 |
|
|
2025
Q4 | $10.2M | Sell |
119,083
-9,270
| -7% | -$761K | 0.01% | 881 |
|
|
2025
Q3 | $9.98M | Sell |
128,353
-4,896
| -4% | -$383K | 0.01% | 919 |
|
|
2025
Q2 | $10.4M | Sell |
133,249
-30,752
| -19% | -$2.29M | 0.01% | 884 |
|
|
2025
Q1 | $11.9M | Buy |
164,001
+443
| +0.3% | +$31.7K | 0.02% | 774 |
|
|
2024
Q4 | $12.1M | Sell |
163,558
-29,569
| -15% | -$2.07M | 0.02% | 735 |
|
|
2024
Q3 | $12.7M | Sell |
193,127
-20,494
| -10% | -$1.49M | 0.02% | 714 |
|
|
2024
Q2 | $19.7M | Buy |
213,621
+32,358
| +18% | +$2.87M | 0.03% | 508 |
|
|
2024
Q1 | $17.3M | Buy |
181,263
+42,744
| +31% | +$3.59M | 0.03% | 545 |
|
|
2023
Q4 | $10.6M | Sell |
138,519
-25,465
| -16% | -$1.77M | 0.02% | 713 |
|
|
2023
Q3 | $11.4M | Buy |
163,984
+11,117
| +7% | +$893K | 0.02% | 626 |
|
|
2023
Q2 | $14.4M | Buy |
152,867
+18,113
| +13% | +$1.57M | 0.03% | 538 |
|
|
2023
Q1 | $11.1K | Buy |
134,754
+12,683
| +10% | +$997K | 0.02% | 614 |
|
|
2022
Q4 | $9.11M | Sell |
122,071
-16,231
| -12% | -$1.25M | 0.02% | 662 |
|
|
2022
Q3 | $11.4M | Buy |
138,302
+2,579
| +2% | +$248K | 0.03% | 528 |
|
|
2022
Q2 | $12.9M | Buy |
135,723
+1,396
| +1% | +$145K | 0.03% | 478 |
|
|
2022
Q1 | $15.8M | Buy |
134,327
+5,885
| +5% | +$660K | 0.04% | 446 |
|
|
2021
Q4 | $16.6M | Buy |
128,442
+45
| +0% | +$5.25K | 0.04% | 429 |
|
|
2021
Q3 | $14.5M | Sell |
128,397
-2,020
| -2% | -$231K | 0.04% | 436 |
|
|
2021
Q2 | $13.5M | Buy |
130,417
+6,957
| +6% | +$656K | 0.03% | 459 |
|
|
2021
Q1 | $10.3M | Sell |
123,460
-4,201
| -3% | -$355K | 0.03% | 509 |
|
|
2020
Q4 | $11.6M | Sell |
127,661
-4,328
| -3% | -$359K | 0.04% | 433 |
|
|
2020
Q3 | $10.5M | Sell |
131,989
-1,520
| -1% | -$119K | 0.04% | 417 |
|
|
2020
Q2 | $9.23M | Buy |
133,509
+20,685
| +18% | +$1.47M | 0.03% | 424 |
|
|
2020
Q1 | $7.09M | Sell |
112,824
-14,673
| -12% | -$1.06M | 0.03% | 444 |
|
|
2019
Q4 | $9.91M | Buy |
127,497
+3,816
| +3% | +$298K | 0.04% | 414 |
|
|
2019
Q3 | $9.07M | Buy |
123,681
+13,566
| +12% | +$953K | 0.04% | 411 |
|
|
2019
Q2 | $6.78M | Buy |
110,115
+21
| +0% | +$1.27K | 0.03% | 477 |
|
|
2019
Q1 | $7.02M | Buy |
110,094
+25,632
| +30% | +$1.46M | 0.03% | 457 |
|
|
2018
Q4 | $4.31M | Buy |
84,462
+4,173
| +5% | +$211K | 0.02% | 541 |
|
|
2018
Q3 | $4.66M | Buy |
80,289
+4,005
| +5% | +$196K | 0.02% | 558 |
|
|
2018
Q2 | $3.7M | Sell |
76,284
-2,913
| -4% | -$136K | 0.02% | 620 |
|
|
2018
Q1 | $3.68M | Buy |
79,197
+8,448
| +12% | +$367K | 0.02% | 593 |
|
|
2017
Q4 | $2.66M | Buy |
70,749
+2,133
| +3% | +$78.3K | 0.01% | 716 |
|
|
2017
Q3 | $2.5M | Buy |
68,616
+3,351
| +5% | +$128K | 0.02% | 698 |
|
|
2017
Q2 | $2.57M | Buy |
65,265
+2,694
| +4% | +$98.3K | 0.02% | 656 |
|
|
2017
Q1 | $1.96M | Buy |
62,571
+9,381
| +18% | +$294K | 0.01% | 752 |
|
|
2016
Q4 | $1.66M | Sell |
53,190
-54
| -0.1% | -$1.75K | 0.01% | 796 |
|
|
2016
Q3 | $2.14M | Sell |
53,244
-6,342
| -11% | -$239K | 0.02% | 658 |
|
|
2016
Q2 | $1.98M | Buy |
59,586
+3,021
| +5% | +$103K | 0.02% | 654 |
|
|
2016
Q1 | $1.66M | Sell |
56,565
-483
| -0.8% | -$13.3K | 0.01% | 714 |
|
|
2015
Q4 | $1.5M | Buy |
57,048
+5,430
| +11% | +$141K | 0.01% | 727 |
|
|
2015
Q3 | $1.22M | Buy |
51,618
+4,776
| +10% | +$115K | 0.01% | 800 |
|
|
2015
Q2 | $1.11M | Sell |
46,842
-16,812
| -26% | -$379K | 0.01% | 897 |
|
|
2015
Q1 | $1.51M | Buy |
63,654
+1,020
| +2% | +$22.9K | 0.02% | 730 |
|
|
2014
Q4 | $1.33M | Buy |
62,634
+8,370
| +15% | +$168K | 0.01% | 750 |
|
|
2014
Q3 | $924K | Sell |
54,264
-1,290
| -2% | -$20.4K | 0.01% | 912 |
|
|
2014
Q2 | $795K | Buy |
55,554
+13,974
| +34% | +$189K | 0.01% | 993 |
|
|
2014
Q1 | $514K | Sell |
41,580
-576
| -1% | -$6.65K | 0.01% | 1143 |
|
|
2013
Q4 | $462K | Sell |
42,156
-3,450
| -8% | -$38.9K | 0.01% | 1174 |
|
|
2013
Q3 | $529K | Buy |
45,606
+3,570
| +8% | +$41.8K | 0.01% | 1068 |
|
|
2013
Q2 | $471K | Buy |
+42,036
| New | +$498K | 0.01% | 1046 |
|
Other funds holding EW
VCM
VPM
Commonwealth Equity Services's EW Position: Q1 2026 in Review
Commonwealth Equity Services reduced its Edwards Lifesciences (EW) stake by 6% in Q1 2026, selling an estimated $587K and leaving 111,964 shares worth $8.97M. The position accounts for 0.01% of the portfolio, ranked #943.
Commonwealth Equity Services first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.7M in Q2 2024. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Commonwealth Equity Services held 111,964 shares of Edwards Lifesciences worth $8.97M as of Q1 2026.
- Commonwealth Equity Services sold 7,119 Edwards Lifesciences shares in Q1 2026, an estimated $587K.
- Edwards Lifesciences made up 0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #943 holding.
- Commonwealth Equity Services first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Commonwealth Equity Services's Edwards Lifesciences position peaked at $19.7M in Q2 2024.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.